Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 24412382)

1.

Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.

Van Hung T, Emoto N, Vignon-Zellweger N, Nakayama K, Yagi K, Suzuki Y, Hirata K.

Life Sci. 2014 Nov 24;118(2):313-28. doi: 10.1016/j.lfs.2013.12.215. Epub 2014 Jan 8.

2.

Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.

Ivy DD, McMurtry IF, Colvin K, Imamura M, Oka M, Lee DS, Gebb S, Jones PL.

Circulation. 2005 Jun 7;111(22):2988-96. Epub 2005 May 31.

3.

Effects of vascular endothelial growth factor on endothelin-1 production by human lung microvascular endothelial cells in vitro.

Star GP, Giovinazzo M, Lamoureux E, Langleben D.

Life Sci. 2014 Nov 24;118(2):191-4. doi: 10.1016/j.lfs.2014.02.032. Epub 2014 Mar 7.

4.

A novel murine model of severe pulmonary arterial hypertension.

Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, Walker C, Westwick J, Thomas M.

Am J Respir Crit Care Med. 2011 Nov 15;184(10):1171-82. doi: 10.1164/rccm.201103-0412OC. Epub 2011 Aug 25.

PMID:
21868504
5.

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Mizuno S, Farkas L, Al Husseini A, Farkas D, Gomez-Arroyo J, Kraskauskas D, Nicolls MR, Cool CD, Bogaard HJ, Voelkel NF.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):679-87. doi: 10.1165/rcmb.2012-0077OC. Epub 2012 Jul 27.

PMID:
22842496
6.

Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.

Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, Loscalzo J, Leopold JA.

Circulation. 2012 Aug 21;126(8):963-74. doi: 10.1161/CIRCULATIONAHA.112.094722. Epub 2012 Jul 11.

7.

The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.

Sakao S, Tatsumi K.

Respiration. 2011;81(3):253-61. doi: 10.1159/000322011. Epub 2010 Nov 30. Review.

PMID:
21116108
8.

Novel dual endothelin receptor antagonist macitentan reverses severe pulmonary arterial hypertension in rats.

Kunita-Takanezawa M, Abe K, Hirooka Y, Kuwabara Y, Hirano K, Oka M, Sunagawa K.

J Cardiovasc Pharmacol. 2014 Nov;64(5):473-80. doi: 10.1097/FJC.0000000000000141.

PMID:
25084082
9.

Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.

Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim DK, Morrell NW.

Circulation. 2009 Feb 3;119(4):566-76. doi: 10.1161/CIRCULATIONAHA.108.821504. Epub 2009 Jan 19.

10.

Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.

Oka M, Homma N, Taraseviciene-Stewart L, Morris KG, Kraskauskas D, Burns N, Voelkel NF, McMurtry IF.

Circ Res. 2007 Mar 30;100(6):923-9. Epub 2007 Mar 1.

11.

Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.

Ciuclan L, Hussey MJ, Burton V, Good R, Duggan N, Beach S, Jones P, Fox R, Clay I, Bonneau O, Konstantinova I, Pearce A, Rowlands DJ, Jarai G, Westwick J, MacLean MR, Thomas M.

Am J Respir Crit Care Med. 2013 Jan 1;187(1):78-89. doi: 10.1164/rccm.201206-1028OC. Epub 2012 Oct 18.

PMID:
23087024
12.

BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production.

Park JE, Shao D, Upton PD, Desouza P, Adcock IM, Davies RJ, Morrell NW, Griffiths MJ, Wort SJ.

PLoS One. 2012;7(1):e30075. doi: 10.1371/journal.pone.0030075. Epub 2012 Jan 27.

14.

Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.

Price LC, Caramori G, Perros F, Meng C, Gambaryan N, Dorfmuller P, Montani D, Casolari P, Zhu J, Dimopoulos K, Shao D, Girerd B, Mumby S, Proudfoot A, Griffiths M, Papi A, Humbert M, Adcock IM, Wort SJ.

PLoS One. 2013 Oct 4;8(10):e75415. doi: 10.1371/journal.pone.0075415. eCollection 2013.

15.

Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.

Ricard N, Tu L, Le Hiress M, Huertas A, Phan C, Thuillet R, Sattler C, Fadel E, Seferian A, Montani D, Dorfmüller P, Humbert M, Guignabert C.

Circulation. 2014 Apr 15;129(15):1586-97. doi: 10.1161/CIRCULATIONAHA.113.007469. Epub 2014 Jan 30.

16.

A novel p38 mitogen-activated protein kinase/Elk-1 transcription factor-dependent molecular mechanism underlying abnormal endothelial cell proliferation in plexogenic pulmonary arterial hypertension.

Patel M, Predescu D, Tandon R, Bardita C, Pogoriler J, Bhorade S, Wang M, Comhair S, Hemnes AR, Chen J, Machado R, Husain A, Erzurum S, Predescu S.

J Biol Chem. 2013 Sep 6;288(36):25701-16. doi: 10.1074/jbc.M113.502674. Epub 2013 Jul 26. Erratum in: J Biol Chem. 2013 Dec 27;288(52):36855. Ryan-Hemnes, Anna [corrected to Hemnes, Anna Ryan].

17.

Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?

Jacobs A, Preston IR, Gomberg-Maitland M.

Curr Med Res Opin. 2006 Dec;22(12):2567-74. Review.

PMID:
17166339
18.

Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.

Derrett-Smith EC, Dooley A, Gilbane AJ, Trinder SL, Khan K, Baliga R, Holmes AM, Hobbs AJ, Abraham D, Denton CP.

Arthritis Rheum. 2013 Nov;65(11):2928-39. doi: 10.1002/art.38078.

19.

BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.

Talati M, West J, Blackwell TR, Loyd JE, Meyrick B.

Am J Physiol Lung Cell Mol Physiol. 2010 Sep;299(3):L363-73. doi: 10.1152/ajplung.00295.2009. Epub 2010 Jun 18.

20.

The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.

Davie NJ, Schermuly RT, Weissmann N, Grimminger F, Ghofrani HA.

Eur J Clin Invest. 2009 Jun;39 Suppl 2:38-49. doi: 10.1111/j.1365-2362.2009.02120.x. Review. Erratum in: Eur J Clin Invest. 2009 Jul;39(7):630.

PMID:
19335746
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk